Keep up with the doctors, patients, treatments—and results—from all our locations.
Patients who deal with chronic migraines often feel as if they are sidelined from life by their conditions. For professional athletes such as Dwayne Wade of the Miami Heat and Terrell Davis of the Denver Broncos, this feeling was a reality on more than one occasion.
Ongoing clinical research studies into the causes of migraines and possible treatments are revealing more options for prevention of episodes. The two major pharmaceutical strategies for the migraine condition are abortive and preventative. The former involves the use of medications that can bring quick pain relief when taken before or during a headache episode; the latter focuses on medicinal regimes that can forestall auras and triggers.
The way business is carried out in the pharmaceutical industry has become extremely dynamic. For pharmaceutical giants such as GlaxoSmithKline, a multinational company based in England, mergers and acquisitions are no longer attractive. The real money is in offering investors to hold some of the rights to certain medications. Such is the case of Imitrex, a triptan drug often prescribed for the treatment of migraines.
As with most other chronic health issues, migraine episodes can strike anytime and thus create a sense of dread and terrible anxiety for patients who feel as if they are forced to live with their adverse conditions. One of the most dreadful aspects of living with migraines is the possibility of a debilitating attack taking place far from home, in an unfamiliar place and during a difficult situation.
A national research study conducted by a major American health services company in 2013 aims to investigate alternative treatment options for patients who live with chronic migraine conditions. One of the practitioners who participated in the study is a Pennsylvania chiropractor who reported that she performs close to 5,000 treatments per year on patients who seek relief from headaches.
In early 2014, the American Medical Association (AMA) published an interesting article about a known psychotherapy technique that many researchers believe could help children to manage their migraine conditions more effectively. Migraines can become manifest in children as early as the age of 10, although this conditions is more likely to affect adolescents.
In a recent interview with a music industry publication in Los Angeles, pop musician Katy Perry revealed that she deals with stage fright and performance anxiety by taking beta blockers, which are medications typically associated with the treatment of migraine conditions. Once she is onstage, Perry actually finds that the loud music she plays for her audience helps her to relax.
recent news release issued by the American Heart Association (AHA) is groundbreaking in the sense that it marks the first time this major health non-profit has recommended guidelines for the prevention of strokes in women. As expected, women who suffer from chronic migraines with aura are believed to be at greater risk of stroke: however, a more alarming risk factor is being discussed by physicians: Pre-eclampsia.
